Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Rani Therapeutics Holdings Inc (NASDAQ: RANI) closed at $6.05 in the last session, down -22.93% from day before closing price of $7.85. In other words, the price has decreased by -$22.93 from its previous closing price. On the day, 0.59 million shares were traded. RANI stock price reached its highest trading level at $7.81 during the session, while it also had its lowest trading level at $5.9.
Ratios:
We take a closer look at RANI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.33 and its Current Ratio is at 6.33. In the meantime, Its Debt-to-Equity ratio is 2.34 whereas as Long-Term Debt/Eq ratio is at 1.90.
On October 11, 2022, UBS started tracking the stock assigning a Buy rating and target price of $15.
On July 27, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $22.H.C. Wainwright initiated its Buy rating on July 27, 2022, with a $22 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 06 ’23 when Imran Talat bought 10,000 shares for $2.27 per share. The transaction valued at 22,700 led to the insider holds 484,455 shares of the business.
Imran Talat bought 5,000 shares of RANI for $12,850 on Dec 04 ’23. The Chief Executive Officer now owns 474,455 shares after completing the transaction at $2.57 per share. On Nov 29 ’23, another insider, Imran Talat, who serves as the Chief Executive Officer of the company, bought 20,000 shares for $2.05 each. As a result, the insider paid 41,000 and bolstered with 469,455 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RANI now has a Market Capitalization of 313148608 and an Enterprise Value of 151684128.
Stock Price History:
Over the past 52 weeks, RANI has reached a high of $8.75, while it has fallen to a 52-week low of $1.82. The 50-Day Moving Average of the stock is 61.65%, while the 200-Day Moving Average is calculated to be 84.62%.
Shares Statistics:
According to the various share statistics, RANI traded on average about 115.30K shares per day over the past 3-months and 346730 shares per day over the past 10 days. A total of 26.04M shares are outstanding, with a floating share count of 11.59M. Insiders hold about 55.48% of the company’s shares, while institutions hold 7.73% stake in the company. Shares short for RANI as of 1711584000 were 1920035 with a Short Ratio of 16.65, compared to 1709164800 on 1714414. Therefore, it implies a Short% of Shares Outstanding of 1920035 and a Short% of Float of 14.140001.
Earnings Estimates
A detailed examination of Rani Therapeutics Holdings Inc (RANI) is currently in progress, with Rani Therapeutics Holdings, Inc analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $2.90, with high estimates of $13.87 and low estimates of $1.80.
Analysts are recommending an EPS of between $Financial Services and $Healthcare for the fiscal current year, implying an average EPS of $Technology.
